Cite Filings / DNLI / 0001193125-21-045177
Feed Companies Filings Check
Sign in
SC 13G/A

Amended Statement of Ownership

Denali Therapeutics Inc. · Filed 2021-02-16 · Acc 0001193125-21-045177

Documents 1

  • SC 13G/A Amended Statement of Ownership , d128528dsc13ga.htm

Around this filing

  • 2022-01-18 SC 13G/A Amended Statement of Ownership
  • 2021-02-16 4 Chief Medical Officer sold 3,156 shares at an average $70.33 ($221,972)
  • 2021-02-16 4 COO and Secretary sold 3,047 shares at an average $70.35 ($214,341)
  • 2021-02-16 4 CFO and Treasurer sold 3,035 shares at an average $70.34 ($213,480)
  • 2021-02-16 4 President and CEO sold 9,473 shares at an average $70.30 ($665,984)
  • 2021-02-16 SC 13G/A Amended Statement of Ownership
  • 2021-02-12 SC 13G/A Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading d128528dsc13ga.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…